Vivo Bio Tech Limited reported earnings results for the second quarter and six months ended September 30, 2021. For the second quarter, the company reported sales was INR 101.68 million compared to INR 146.65 million a year ago. Revenue was INR 101.98 million compared to INR 146.65 million a year ago. Net income was INR 2.77 million compared to INR 21.04 million a year ago. Basic earnings per share from continuing operations was INR 0.2 compared to INR 1.63 a year ago. Diluted earnings per share from continuing operations was INR 0.19 compared to INR 1.63 a year ago. For the six months, sales was INR 231.65 million compared to INR 238.19 million a year ago. Revenue was INR 234.16 million compared to INR 238.19 million a year ago. Net income was INR 15.17 million compared to INR 30.82 million a year ago. Basic earnings per share from continuing operations was INR 1.07 compared to INR 2.39 a year ago. Diluted earnings per share from continuing operations was INR 1.02 compared to INR 2.39 a year ago.